HH-006 / Huahui Health - LARVOL DELTA

Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection (clinicaltrials.gov) - P2 | N=45 | Recruiting | Sponsor: Huahui Health | Not yet recruiting ➔ Recruiting

Enrollment open • Hepatitis B • Infectious Disease • Inflammation

A phase Ib multiple dose ascending study of HH-006 in treatment-naïve participants with chronic hepatitis B virus infection (EASL 2026) - "HH-006 was safe and well-tolerated and demonstrated antiviral activity, with an approximately dose‑proportional PK profile, in treatment‑naïve patients with CHB. Further studies are warranted to explore HH-006's potential as single agent or combination use for functional cure of HBV."

Late-breaking abstract • P1 data • Hepatitis B • Hepatology • Infectious Disease • Inflammation

Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection (clinicaltrials.gov) - P2 | N=45 | Not yet recruiting | Sponsor: Huahui Health

New P2 trial • Hepatitis B • Infectious Disease • Inflammation

A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected Patients (clinicaltrials.gov) - P1 | N=36 | Completed | Sponsor: Huahui Health

New P1 trial • Hepatitis B • Infectious Disease • Inflammation

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=33 | Completed | Sponsor: Huahui Health | Recruiting ➔ Completed

Trial completion • Hepatitis B • Hepatology • Infectious Disease • Inflammation

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: Huahui Health | Not yet recruiting ➔ Recruiting

Enrollment open • Hepatitis B • Hepatology • Infectious Disease • Inflammation

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=32 | Not yet recruiting | Sponsor: Huahui Health

New P1 trial • Hepatitis B • Hepatology • Infectious Disease • Inflammation